[Federal Register Volume 71, Number 9 (Friday, January 13, 2006)]
[Notices]
[Page 2254]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-312]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Topic 206 ``Methods for Innovative Pharmaceutical 
Manufacturing & Quality Assurance''.
    Date: March 8, 2006.
    Time: 11 a.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Rockville, MD 20852. (Telephone Conference Call).
    Contact Person: Lalita Palekar, PhD, Scientific Review 
Administration, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Blvd., Room 8105, Bethesda, MD 
20892-7405. (301) 496-7575.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Consruction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93:398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)
    Dated: January 5, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committe Policy.
[FR Doc. 06-312 Filed 1-12-06; 8:45 am]
BILLING CODE 4140-01-M